Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127744991 | 12774499 | 1 | I | 2014 | 20160919 | 20160923 | 20160923 | EXP | PHHY2016BR130245 | NOVARTIS | 0.00 | F | Y | 70.00000 | KG | 20160923 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127744991 | 12774499 | 1 | PS | DIOVAN | VALSARTAN | 1 | Oral | 2 DF, QD | U | 21283 | 2 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127744991 | 12774499 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127744991 | 12774499 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127744991 | 12774499 | Body height decreased | |
| 127744991 | 12774499 | Cataract | |
| 127744991 | 12774499 | Eyelid ptosis | |
| 127744991 | 12774499 | Fall | |
| 127744991 | 12774499 | Gait disturbance | |
| 127744991 | 12774499 | Movement disorder | |
| 127744991 | 12774499 | Neuralgia | |
| 127744991 | 12774499 | Pain in extremity | |
| 127744991 | 12774499 | Thrombosis | |
| 127744991 | 12774499 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |